IP Verse

Alfa Wassermann S.p.a. opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Nov 1, 2017

Title:

Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease

Oppositions:

Patent:

Grant Date:

Jun 7, 2017

Title:

Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved

Oppositions:

Patent:

Grant Date:

Apr 19, 2017

Title:

Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP2618819	Nov 1, 2017	Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease	1
EP2560662	Jun 7, 2017	Sulodexide For Use In The Treatment Of Pathologies Wherein Metalloproteinases Are Involved	2
EP2059232	Apr 19, 2017	Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin	3

SANDOZ GMBH

BOTTI & FERRARI S.R.L.

GENERICS (U.K.) LIMITED

Feel free to send us a message here and we will get back to you